Synthesis, Characterization, and Antitumor Activity of Some Metal Complexes with Schiff Bases Derived from 9-Fluorenone as a Polycyclic Aromatic Compound

Abstract

New bidendate Schiff base ligands HL1 [(9H-fluorene-9-ylidene)-thiosemicarbazide], HL2 [(9H-fluorene-9-ylidene)semicarbazide] and L3 [N 1,N 2-di(9H-fluorene-9-ylidene)ethan-1,2-diamine] derived from the condensation of thiosemicarbazide, semicarbazide, and ethylenediamine with 9-fluorenone as polycyclic aromatic compound (PAC). Ag(I), Cu(II), VO(IV), La(III), and Zn(II) of the ligands HL1, HL2, and L3 have been prepared and characterized by conductance and magnetic measurements, and electronic, infrared, and 1H NMR spectral data. Tetrahedral structures are suggested for Ag (I) with HL1, HL2, and L3, whereas Cu(II)-HL1 and VO(IV)-HL2 have octahedral and square-planar structures, respectively. The Erlich antitumor activity in vivo (E. A. A.) have been studied and showed that the free ligands L3, HL2, and its VO(IV)-HL2 complex are the most active in the inhibition of cell viability, whereas the ligands HL1, La(III) -L3, and Cu(II)-HL1 are the least active ones.